Reaching the age of 90, 95 or 100, known as exceptional longevity, was more likely for women who maintained their body weight after age 60, according to a multi-institutional study led by University of California San Diego. ...
Aug 29, 2023
0
2
Following native tissue transvaginal prolapse repair, perioperative vaginal estrogen does not reduce prolapse recurrence, according to a study published in the Aug. 15 issue of the Journal of the American Medical Association.
Aug 21, 2023
0
3
New research published in The FASEB Journal indicates that increasing the expression of a particular gene may help to prevent bone loss associated with postmenopausal osteoporosis.
Aug 9, 2023
0
8
Approximately 65% of adults in the United States consume sugar sweetened beverages daily. Chronic liver disease is a major cause of morbidity and mortality worldwide and can result in liver cancer and liver disease-related ...
Aug 8, 2023
0
6
Pelvic floor disorders (PFDs), which occur when women's pelvic floor muscles are weakened or injured, significantly affect quality of life and require surgery for hundreds of thousands in the U.S. each year. Now a study led ...
Jul 5, 2023
0
1
Recurrent cystitis (RC) is a frequent infection of the urinary tract and bladder, which is highly prevalent among postmenopausal women. Under healthy circumstances, the human vagina is home to a host of beneficial intestinal ...
Jul 3, 2023
0
27
Whether hormone therapy (HT) can be linked to an increased risk of gastroesophageal reflux disease (GERD) has been debated for years. A new systematic review and meta-analysis attempts to resolve the controversy, suggesting ...
Jun 28, 2023
0
2
Osteoporosis is a degenerative, debilitating bone disease that is increasingly prevalent in postmenopausal women. Despite its being classified as one of the four most dangerous health issues today, a new study demonstrated ...
Jun 7, 2023
0
14
For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longer progression-free ...
Jun 5, 2023
0
0
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone therapy there are a significant invasive disease-free survival benefit in patients ...
Jun 2, 2023
0
7
